Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Koopmans

Showing results (251-260 of 328) with videos related to

Pageof 33
Sort By:
British Journal of Clinical Pharmacology|June 26, 2001
The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individualsC H Koks, K M Crommentuyn, R M Hoetelmans, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1996
Anti-toxoplasma effect of pyrimethamine, trimethoprim and sulphonamides alone and in combination: implications for therapyA J van der Ven, E M Schoondermark-van de Ven, W Camps, et al.
Clinical and Diagnostic Laboratory Immunology|January 10, 1998
Evaluation of a poliovirus-binding inhibition assay as an alternative to the virus neutralization testM M Herremans, J H Reimerink, A Ras, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2007
Interaction study of the combined use of paroxetine and fosamprenavir-ritonavir in healthy subjectsManon J van der Lee, Audrey A M Blenke, Gerard A Rongen, et al.
The Netherlands Journal of Medicine|October 6, 2004
Ocular syphilis acquired through oral sex in two HIV-infected patientsM B B McCall, J J C van Lith-Verhoeven, R van Crevel, et al.
AIDS (London, England)|June 17, 2005
Pharmacokinetics of once-daily lopinavir/ritonavir and the influence of dose modificationsCharles J L la Porte, Emile F Schippers, Marchina E van der Ende, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteersC J L la Porte, E P H Colbers, R Bertz, et al.
Anticancer Research|October 30, 2004
Outcome of local application of amifostine (WR-1065) on epirubicin-induced oral mucositis. A phase II studyM A Stokman, F M Wachters, P Koopmans, et al.
Clinical Pharmacology and Therapeutics|February 2, 2002
The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteersRob E Aarnoutse, Karin J T Grintjes, Denise S C Telgt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomographyKlaas P Koopmans, Oliver C Neels, Ido P Kema, et al.
Pageof 33

Showing results (251-260 of 328) with videos related to

Sort By:
Pageof 33
British Journal of Clinical Pharmacology|June 26, 2001
The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individualsC H Koks, K M Crommentuyn, R M Hoetelmans, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 1996
Anti-toxoplasma effect of pyrimethamine, trimethoprim and sulphonamides alone and in combination: implications for therapyA J van der Ven, E M Schoondermark-van de Ven, W Camps, et al.
Clinical and Diagnostic Laboratory Immunology|January 10, 1998
Evaluation of a poliovirus-binding inhibition assay as an alternative to the virus neutralization testM M Herremans, J H Reimerink, A Ras, et al.
Antimicrobial Agents and Chemotherapy|September 12, 2007
Interaction study of the combined use of paroxetine and fosamprenavir-ritonavir in healthy subjectsManon J van der Lee, Audrey A M Blenke, Gerard A Rongen, et al.
The Netherlands Journal of Medicine|October 6, 2004
Ocular syphilis acquired through oral sex in two HIV-infected patientsM B B McCall, J J C van Lith-Verhoeven, R van Crevel, et al.
AIDS (London, England)|June 17, 2005
Pharmacokinetics of once-daily lopinavir/ritonavir and the influence of dose modificationsCharles J L la Porte, Emile F Schippers, Marchina E van der Ende, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Pharmacokinetics of adjusted-dose lopinavir-ritonavir combined with rifampin in healthy volunteersC J L la Porte, E P H Colbers, R Bertz, et al.
Anticancer Research|October 30, 2004
Outcome of local application of amifostine (WR-1065) on epirubicin-induced oral mucositis. A phase II studyM A Stokman, F M Wachters, P Koopmans, et al.
Clinical Pharmacology and Therapeutics|February 2, 2002
The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteersRob E Aarnoutse, Karin J T Grintjes, Denise S C Telgt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 20, 2008
Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomographyKlaas P Koopmans, Oliver C Neels, Ido P Kema, et al.
Pageof 33